Immunocore Holdings (IMCR)
NASDAQ:IMCR
Holding IMCR?
Track your performance easily

Immunocore Holdings (IMCR) Income Statement

160 Followers

Immunocore Holdings Income Statement

Last quarter (Q4 2022), Immunocore Holdings's total revenue was £48.06M, an increase of 628.99% from the same quarter last year. In Q4, Immunocore Holdings's net income was £-25.20M. See Immunocore Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
£ 143.74M£ 249.43M£ 143.74M£ 26.52M£ 30.11M£ 25.67M
Cost of Revenue
£ 454.00K£ 1.04M£ 454.00K-£ 0.00-
Gross Profit
£ 143.28M£ 248.39M£ 143.28M£ 26.52M£ 30.11M-
Operating Expense
£ 180.51M£ 308.94M£ 182.89M£ 161.63M£ 119.40M£ 144.17M
Operating Income
£ -37.23M£ -60.55M£ -39.61M£ -135.10M£ -89.29M£ -118.50M
Net Non Operating Interest Income Expense
£ -4.54M£ 12.83M£ -4.54M£ -5.77M£ -2.40M£ -2.40M
Other Income Expense
£ -2.38M-£ -3.00K£ 57.00K£ 4.33M£ -5.28M
Pretax Income
£ -44.15M£ -60.89M£ -44.15M£ -140.93M£ -87.36M£ -126.19M
Tax Provision
£ -2.92M£ -5.60M£ -2.92M£ -9.40M£ -13.27M£ -22.26M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
£ -41.22M£ -55.29M£ -41.22M£ -131.52M£ -74.09M£ -103.93M
Basic EPS
£ -0.92£ -1.13£ -0.90£ -3.10£ -2.33£ >-0.01
Diluted EPS
£ -0.93£ -1.13£ -0.90£ -3.10£ -2.33£ >-0.01
Basic Average Shares
£ 182.83M£ 48.89M£ 45.71M£ 42.49M£ 31.78M£ 22.30B
Diluted Average Shares
£ 187.27M£ 48.89M£ 45.71M£ 42.49M£ 31.78M£ 22.30B
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
-----£ <0.01
Reported Normalized Diluted E P S
-----£ <0.01
Rent Expense Supplemental
------
Total Expenses
£ 180.97M£ 309.97M£ 183.35M-£ 119.40M£ 144.17M
Net Income From Continuing And Discontinued Operation
£ -41.22M£ -55.29M£ -41.22M£ -131.52M£ -74.09M£ -103.93M
Normalized Income
£ -40.75M£ -66.49M£ -47.07M£ -150.33M£ -74.24M£ -99.43M
Interest Expense
£ 6.30M---£ 3.11M£ 3.80M
EBIT
£ -37.85M£ -55.74M£ -36.45M£ -135.16M£ -84.25M£ -122.39M
EBITDA
£ -31.71M£ -51.65M£ -30.32M-£ -75.28M£ -113.18M
Currency in GBP

Immunocore Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis